Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.
D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D001158:Arteries / Q000201:enzymology; D001593:Benzyl Compounds / Q000494:pharmacology; D002421:Caudate Nucleus / Q000201:enzymology; D002540:Cerebral Cortex / Q000201:enzymology; D006152:Cyclic GMP / Q000378:metabolism; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology*; D004987:Ethers / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology*; D008638:Mesenteric Arteries / Q000201:enzymology; D008738:Methyl Ethers / Q000494:pharmacology; D009130:Muscle, Smooth / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D009638:Norepinephrine / Q000494:pharmacology; D009928:Organ Specificity; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000097:blood; D051381:Rats; D013329:Structure-Activity Relationship; D013806:Theophylline / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014680:Veins / Q000201:enzymology
D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D008738:Methyl Ethers; D010726:Phosphodiesterase Inhibitors; D013806:Theophylline; D010208:Papaverine; D010727:Phosphoric Diester Hydrolases; D006152:Cyclic GMP; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine